Max Health is pleased to confirm that is has been awarded the tender for all three strengths of Octreotide Injection – 50mcg/mL in 1mL; 100mcg/mL in 1mL; 500mcg/mL in 1mL. These are supplied by our Australian partner, Generic Health. Octreotide Injections will be listed in both sections H and B of the Pharmaceutical Schedule and will have Principal Supply Status until 30 June 2024.
This change in subsidy will occur on February 1st 2022.
Distribution of all Max Health products, including Octreotide Injections, are managed by Onelink. These can be ordered from:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Octreotide Injection details are as follows:
Name: Octreotide Injection
Strength: 50mcg/mL in 1mL x 5
Onelink Code: PHAX70
Price: POA
Name: Octreotide Injection
Strength: 100mcg/mL in 1mL x 5
Onelink Code: PHAX71
Price: POA
Name: Octreotide Injection
Strength: 500mcg/mL in 1mL x 5
Onelink Code: PHAX72
Price: POA